IP Library Assignment 030739/0950
Patent Assignment
Reel/Frame 030739/0950

Property Transfer Scheme

Recorded: 2013-07-02 Pages: 5
Assignor
HEALTH PROTECTION AGENCY
Executed: 2013-03-12
Assignee
THE SECRETARY OF STATE FOR HEALTH
79 WHITEHALL, RICHMOND HOUSE, LONDON, SW1A 2NS, UNITED KINGDOM
Covered Properties (47)
Multicomponent meningococcal vaccine
Application: 10/320,800 →
Publication: US US20030215469A1
Recombinant toxin fragments
Application: 10/527,411 →
Publication: US US20060110410A1
Recombinant Toxin Fragments
Patent: 9,006,395 →
Application: 12/900,214 →
Publication: US US20110028691A1
Modified whole cell, cell extract and omv-based vaccines
Application: 10/575,070 →
Publication: US US20070154495A1
TB resistance assay
Application: 11/502,676 →
Publication: US US20100273146A1
Mycoplasma Genitalium Detection Assay Based on the MG219 Gene
Patent: 8,778,611 →
Application: 12/302,752 →
Publication: US US20100089751A1
Detection of Human Papillomavirus
Patent: 8,741,568 →
Application: 12/526,462 →
Publication: US US20100143885A1
Covalently Linked Thermostable Kinase for Decontamination Process Validation
Patent: 9,416,396 →
Application: 12/918,628 →
Publication: US US20110177539A1
Proteins with Improved Solubility and Methods for Producing and Using Same
Application: 12/083,096 →
Publication: US US20090269358A1
Radiation Detection
Patent: 9,529,101 →
Application: 12/742,875 →
Publication: US US20100301222A1
Chemically Modified Peptides with Improved Immunogenicity
Patent: 8,883,172 →
Application: 12/664,218 →
Publication: US US20100291152A1
Botulinum Neurotoxin Vaccine
Application: 12/682,544 →
Publication: US US20100297180A1
Rapid Detection of Mycobacteria
Patent: 9,150,930 →
Application: 12/937,263 →
Publication: US US20110097725A1
Rapid Bioluminescence Detection Assay
Patent: 8,512,970 →
Application: 13/143,722 →
Publication: US US20110318729A1
Salmonella Detection Assay
Application: 12/995,428 →
Publication: US US20110244453A1
Antibodies to Clostridium Difficile Toxins
Patent: 8,709,428 →
Application: 13/202,557 →
Publication: US US20120121607A1
Clostridium Difficile Antigens
Application: 13/878,150 →
Publication: US US20130266583A1
Therapies for Preventing or Suppressing Clostridium Difficile Infection
Patent: 8,921,529 →
Application: 13/513,555 →
Publication: US US20130004561A1
Assay Method and Apparatus
Application: 13/513,339 →
Publication: US US20120324984A1
Mycobacterial Antigen Composition
Patent: 9,339,534 →
Application: 13/699,394 →
Publication: US US20130142800A1
Genetically Stable Attenuated Polioviruses Comprising Multiple Mutations in Domain V of the 5' Noncoding Region.
Patent: 8,557,252 →
Application: 12/377,041 →
Publication: US US20100158945A1
Outer Membrane Vesicle Prime-Protein Boost Vaccine
Application: 13/062,168 →
Publication: US US20110262484A1
Expression of Polypeptides in E. Coli Under Control of the E. Coli Mdh-Gene Promoter
Patent: 5,670,333 →
Application: 08/211,682 →
Type F Botulinum Toxin and Use Thereof
Patent: 7,041,792 →
Application: 08/981,087 →
Publication: US US20020081304A1
Recombinant Toxin Fragments
Patent: 7,192,596 →
Application: 10/241,596 →
Publication: US US20030166238A1
Recombinant Toxin Fragments
Patent: 7,674,470 →
Application: 11/077,550 →
Publication: US US20050244435A1
Recombinant Toxin Fragments
Patent: 8,012,491 →
Application: 12/369,341 →
Publication: US US20100022751A1
Recombinant Toxin Fragments
Patent: 6,461,617 →
Application: 09/255,829 →
Publication: US US20020044950A1
Assay with Reduced Background
Patent: 6,913,896 →
Application: 09/889,520 →
Preparation of Highly Pure Toxin Fragments
Patent: 7,193,066 →
Application: 10/070,764 →
Degradation and Detection of Tse Infectivity
Patent: 8,110,391 →
Application: 11/871,087 →
Publication: US US20080178306A1
Degradation and Detection of Tse Infectivity
Patent: 7,303,907 →
Application: 10/614,370 →
Publication: US US20040091474A1
Mycobacterial Antigens Expressed Under Low Oxygen Tension
Patent: 7,393,539 →
Application: 10/481,265 →
Publication: US US20040254349A1
Mycobacterial Antigens Expressed During Latency
Patent: 8,003,776 →
Application: 12/140,163 →
Publication: US US20090082296A1
Mycobacterial Antigens Expressed During Latency
Patent: 7,393,540 →
Application: 10/482,706 →
Publication: US US20040241826A1
Mycobacterial Genes Down-Regulated During Latency
Patent: 7,811,588 →
Application: 10/493,462 →
Publication: US US20040253711A1
Metalloprotease Assay
Patent: 7,670,796 →
Application: 10/557,717 →
Publication: US US20070148694A1
Biological Indicator
Patent: 8,389,208 →
Application: 10/599,098 →
Publication: US US20090317794A1
Stable Compositions Containing Omvs
Patent: 7,820,185 →
Application: 11/632,794 →
Publication: US US20090041807A1
Bacillus Anthracis Protective Antigen
Patent: 7,355,027 →
Application: 11/153,865 →
Publication: US US20080020001A1
Preparation of Protective Antigen
Patent: 8,101,735 →
Application: 12/042,150 →
Publication: US US20090042282A1
Detection of Nucleic Acid Mutations by Detecting the Presence of Heteroduplexes
Patent: 7,935,480 →
Application: 11/722,703 →
Publication: US US20080261200A1
Proteins with Improved Solubility and Methods for Producing and Using Same
Patent: 8,372,405 →
Application: 13/252,671 →
Publication: US US20120034239A1
Monocyte Activation Test Better Able to Detect Non-Endotoxin Pyrogenic Contaminants in Medical Products
Patent: 7,736,863 →
Application: 11/613,866 →
Publication: US US20070184496A1
Pyrogenicity Test for Use with Automated Immunoassay Systems
Patent: 6,696,261 →
Application: 09/727,561 →
Publication: US US20010034037A1
Multicomponent Meningococcal Vaccine
Patent: 6,821,521 →
Application: 09/830,854 →
Neisserial Vaccine Compositions and Methods
Patent: 7,157,245 →
Application: 09/942,583 →
Publication: US US20030026809A1
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 18, 2007
From: BROWN, TIMOTHY
To: HEALTH PROTECTION AGENCY
Reel/Frame 019844/0153 →
Assignment of Assignor's Interest Feb 10, 2009
From: SHONE, CLIFFORD CHARLES; FOSTER, KEITH ALAN; CHADDOCK, JOHN; MARKS, PHILIP
To: HEALTH PROTECTION AGENCY
Reel/Frame 022234/0408 →
License Apr 29, 2009
From: HEATH PROTECTION AGENCY
To: SYNTAXIN LIMITED
Reel/Frame 022610/0001 →
Assignment of Assignor's Interest Dec 17, 2009
From: CHALKER, VICKI; ISON, CATHY
To: HEALTH PROTECTION AGENCY
Reel/Frame 023669/0435 →
Assignment of Assignor's Interest Jan 6, 2010
From: CORLESS, CAROLINE; GUIVER, MALCOLM
To: HEALTH PROTECTION AGENCY
Reel/Frame 023744/0372 →
Assignment of Assignor's Interest Mar 17, 2010
From: GORRINGE, ANDREW R.; REDDIN, KAREN M.
To: HEALTH PROTECTION AGENCY
Reel/Frame 024090/0590 →
Assignment of Assignor's Interest Mar 17, 2010
From: GRAY-OWEN, SCOTT D.; BOULTON, IAN C.
To: HEALTH PROTECTION AGENCY
Reel/Frame 024090/0407 →
Assignment of Assignor's Interest Aug 3, 2010
From: SHONE, CLIFFORD C.
To: HEALTH PROTECTION AGENCY
Reel/Frame 024782/0347 →
Assignment of Assignor's Interest Aug 3, 2010
From: TONG, XIAOMI; CLANCY, JOANNA; GU, MILI
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 024782/0191 →
Assignment of Assignor's Interest Aug 9, 2010
From: SHONE, CLIFFORD C.
To: HEALTH PROTECTION AGENCY; EMERGENT BIOSOLUTIONS, INC.
Reel/Frame 024808/0792 →
Assignment of Assignor's Interest Aug 11, 2010
From: TANNER, RICK; EAKINS, JONATHAN
To: HEALTH PREOTECTION AGENCY
Reel/Frame 024825/0781 →
Assignment of Assignor's Interest Dec 21, 2010
From: ARNOLD, CATHERINE
To: HEALTH PROTECTION AGENCY
Reel/Frame 025548/0026 →
Assignment of Assignor's Interest Apr 6, 2011
From: SUTTON, J. MARK; HESP, J. RICHARD; UNGURS, MICHAEL
To: HEALTH PROTECTION AGENCY
Reel/Frame 026083/0252 →
Assignment of Assignor's Interest Jun 13, 2011
From: HOPKINS, KATIE; LAWSON, ANDY
To: HEALTH PROTECTION AGENCY
Reel/Frame 026435/0348 →
Assignment of Assignor's Interest Aug 15, 2011
From: SUTTON, MARK J.; HESP, RICHARD J.; POOLMAN, TORYN
To: HEALTH PROTECTION AGENCY
Reel/Frame 026752/0129 →
Assignment of Assignor's Interest Nov 1, 2011
From: SHONE, CLIFFORD; LANDON, JOHN
To: HEALTH PROTECTION AGENCY; MICROPHARM LIMITED
Reel/Frame 027155/0004 →
Assignment of Assignor's Interest Sep 10, 2012
From: LANDON, JOHN
To: MICROPHARM LIMITED
Reel/Frame 028929/0621 →
Assignment of Assignor's Interest Sep 10, 2012
From: SHONE, CLIFFORD; ROBERTS, APRIL
To: HEALTH PROTECTION AGENCY
Reel/Frame 028929/0549 →
Assignment of Assignor's Interest Sep 19, 2012
From: WAKEFIELD, JAMES; CHILCOTT, ROBERT
To: HEALTH PROTECTION AGENCY
Reel/Frame 028985/0613 →
Assignment of Assignor's Interest Jan 4, 2013
From: EMERGENT BIOSOLUTIONS INC.
To: HEALTH PROTECTION AGENCY
Reel/Frame 029569/0199 →
Assignment of Assignor's Interest Jan 7, 2013
From: EMERGENT BIOLOSUTIONS INC.
To: HEALTH PROTECTION AGENCY
Reel/Frame 029577/0537 →
Assignment of Assignor's Interest Feb 11, 2013
From: CARROLL, MILES; HALL, YPER; WILLIAMS, ANN
To: HEALTH PROTECTION AGENCY
Reel/Frame 029789/0535 →
Assignment of Assignor's Interest Jun 25, 2013
From: SHONE, CLIFFORD; ROBERTS, APRIL; AHERN, HELEN; MAYNARD-SMITH, MICHAEL
To: HEALTH PROTECTION AGENCY; MICROPHARM LIMITED
Reel/Frame 030680/0985 →
Nunc Pro Tunc Assignment Sep 19, 2019
From: THE SECRETARY OF STATE FOR HEALTH
To: SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE
Reel/Frame 052144/0237 →